The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 38,856 | 2,672,346 | SH | SOLE | 2,672,346 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 7,985 | 815,667 | SH | SOLE | 815,667 | 0 | 0 | |||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,450 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 25,153 | 3,124,613 | SH | SOLE | 3,124,613 | 0 | 0 | |||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 15,491 | 481,094 | SH | SOLE | 481,094 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 19,574 | 2,281,315 | SH | SOLE | 2,281,315 | 0 | 0 | |||
| CELCUITY INC | COM | 15102K100 | 12,141 | 920,464 | SH | SOLE | 920,464 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 18,319 | 5,419,896 | SH | SOLE | 5,419,896 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 32,113 | 704,537 | SH | SOLE | 704,537 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 3,628 | 305,125 | SH | SOLE | 305,125 | 0 | 0 | |||
| GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 3,573 | 3,079,756 | SH | SOLE | 3,079,756 | 0 | 0 | |||
| IVERIC BIO INC | COM | 46583P102 | 53,791 | 3,217,163 | SH | SOLE | 3,217,163 | 0 | 0 | |||
| INVENTIVA SA | ADS | 46124U107 | 3,588 | 262,658 | SH | SOLE | 262,658 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,135 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | |||
| KRONOS BIO INC | COM | 50107A104 | 4,061 | 298,839 | SH | SOLE | 298,839 | 0 | 0 | |||
| MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 3,128 | 1,954,970 | SH | SOLE | 1,954,970 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 47,665 | 1,498,890 | SH | SOLE | 1,498,890 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,888 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 27,551 | 805,573 | SH | SOLE | 805,573 | 0 | 0 | |||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 16,701 | 3,711,286 | SH | SOLE | 3,711,286 | 0 | 0 | |||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 9,739 | 513,930 | SH | SOLE | 513,930 | 0 | 0 | |||
| TRICIDA INC | COM | 89610F101 | 11,922 | 1,247,043 | SH | SOLE | 1,247,043 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 16,759 | 847,683 | SH | SOLE | 847,683 | 0 | 0 | |||
| VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 16,507 | 8,464,999 | SH | SOLE | 8,464,999 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 34,056 | 1,090,126 | SH | SOLE | 1,090,126 | 0 | 0 | |||